Bausch Health Companies: Undervalued by 91.4%?

Bausch Health Companies' share price has declined 2.9% in the last week, 20.4% in the past month, and 22.7% in the last year. Despite this, the stock is undervalued by 91.4% according to a Discounted Cash Flow (DCF) analysis, which suggests an intrinsic value of $66.77 per share. The company's restructuring efforts and shifting expectations around key product lines have kept investor attention.